Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 55 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1997Laparoscopic versus open splenectomy for immune thrombocytopenia purpuraWatson, D.; Coventry, B.; Chin, T.; Gill, P.; Malycha, P.
2012Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBurmeister, B.; Henderson, M.; Ainslie, J.; Fisher, R.; Di Iulio, J.; Smithers, B.; Hong, A.; Shannon, K.; Scolyer, R.; Carruthers, S.; Coventry, B.; Babington, S.; Duprat, J.; Hoekstra, H.; Thompson, J.
2001Acquired haemophilia in South Australia: a case seriesBurnet, S.; Duncan, E.; Lloyd, J.; Han, P.
2009Clinical Validation and Comparison of Alternative Methods for Evaluation of Entrainment MappingDerejko, P.; Szumowski, L.; Sanders, P.; Dimitri, H.; Kuklik, P.; Przybylski, A.; Urbanek, P.; Szufladowicz, E.; Bodalski, R.; Sacher, F.; Haissaguerre, M.; Walczak, F.
2007Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporineRuss, G.; Jamieson, N.; Oberbauer, R.; Arias, M.; Murgia, C.; Blancho, G.; Sato, R.; Stoeckl, M.; Revicki, D.
2013Smoking termination opportunity for in patients (STOP): Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: A 12-month randomised controlled trial for inpatientsSmith, B.; Carson, K.; Brinn, M.; Labiszewski, N.; Peters, M.; Fitridge, R.; Koblar, S.; Jannes, J.; Veale, A.; Goldsworthy, S.; Litt, J.; Edwards, D.; Esterman, A.
2007Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcomeMcDonald, S.; Russ, G.; Campbell, S.; Chadban, S.
2010Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)Hughes, T.; Hochhaus, A.; Branford, S.; Muller, M.; Kaeda, J.; Foroni, L.; Druker, B.; Guilhot, F.; Larson, R.; O'Brien, S.; Rudoltz, M.; Mone, M.; Wehrle, E.; Modur, V.; Goldman, J.; Radich, J.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2011Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsKantarjian, H.; Giles, F.; Bhalla, K.; Pinilla-Ibarz, J.; Larson, R.; Gattermann, N.; Ottmann, O.; Hochhaus, A.; Radich, J.; Saglio, G.; Hughes, T.; Martinelli, G.; Kim, D.; Shou, Y.; Gallagher, N.; Blakesley, R.; Baccarani, M.; Cortes, J.; le Coutre, P.